Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments
Introduction Pulmonary toxicities are considered a relative common side effect of anticancer drugs. Lung toxicity reported in oncology clinical trial ranges from 10–20% of all patients treated with any type of antineoplastic agents.1 In particular, in …